Jump to main content
eTG Complete
Index
Search
Home
Cardiovascular
Antithrombotic therapy after endovascular and cardiac interventions
Cardiovascular
Atherosclerotic cardiovascular disease risk estimation
Modifiable lifestyle risk factors for atherosclerotic cardiovascular disease
Lipid modification
Blood pressure reduction
Acute chest pain of possible cardiac origin
Acute coronary syndromes
Stable angina
Antithrombotic therapy after endovascular and cardiac interventions
Overview of antithrombotic therapy after endovascular and cardiac interventions
Antithrombotic therapy after insertion of a coronary artery stent
Antithrombotic therapy after insertion of a femoral or carotid artery stent
Antithrombotic therapy after transcatheter aortic valve implantation
Antithrombotic therapy after transcatheter mitral valve repair
Antithrombotic therapy after surgical heart valve replacement
Antithrombotic therapy after aneurysm repair
References
Secondary prevention of atherosclerotic cardiovascular events
Peripheral artery disease
Pericarditis
Heart failure
Cardiac rehabilitation programs
Tachyarrhythmias
Bradyarrhythmias
Orthostatic hypotension
Pulmonary hypertension
Venous thromboembolism
Periprocedural management of patients with cardiovascular disease
Principles of anticoagulant therapy
Antithrombotic therapy after endovascular and cardiac interventions
Published
June 2023
Overview of antithrombotic therapy after endovascular and cardiac interventions
Antithrombotic therapy after insertion of a coronary artery stent
Antithrombotic therapy after insertion of a femoral or carotid artery stent
Antithrombotic therapy after transcatheter aortic valve implantation
Antithrombotic therapy after transcatheter mitral valve repair
Antithrombotic therapy after surgical heart valve replacement
Antithrombotic therapy after aneurysm repair
